National Prescription Services Inc. dba HRI Pharmacy
FDA inspection history in Warrenville, Illinois, 2014
- 1
- Form 483
Every document, by year
- Form 483
2014: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2014One Form 483, at Warrenville, Illinois.
Cited most
Across all National Prescription Services Inc. dba HRI Pharmacy observations on file
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.166(a)Stability testing1
- 21 CFR 211.67(a)Equipment cleaning and maintenance1
- 21 CFR 211.84(d)(2)Testing and approval or rejection of components, drug product containers, and closures1
The complete National Prescription Services Inc. dba HRI Pharmacy file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Warrenville, Illinois
One Form 483 · 2014 · 5 observations
Latest: Form 483, Nov 24, 2014 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2014-11-24 | 483 Form 483 | Warrenville, Illinois | 5 | $99 |
Investigators on these documents
FEI number 3011082190 · most recent document Nov 24, 2014
About National Prescription Services Inc. dba HRI Pharmacy
How many FDA Form 483s has National Prescription Services Inc. dba HRI Pharmacy received?
FDA Intel has 1 Form 483 on file for National Prescription Services Inc. dba HRI Pharmacy; the most recent is dated Nov 24, 2014.
When was National Prescription Services Inc. dba HRI Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for National Prescription Services Inc. dba HRI Pharmacy is a Form 483 dated Nov 24, 2014, for the site in Warrenville, Illinois.
What did FDA cite at National Prescription Services Inc. dba HRI Pharmacy?
The regulations cited most in the observations on file for National Prescription Services Inc. dba HRI Pharmacy are 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.165(a) (Testing and release for distribution), 1 time; 21 CFR 211.166(a) (Stability testing), 1 time.